The Angel PRP System is intended to be used in the clinic or intraoperatively at the point-of care for the safe and rapid preparation of platelet rich plasma from a small sample of whole blood or a small mixture of blood and bone marrow. The system is designed to produce consistently high platelet yields using a fully automated process and represents a significant engineering advance in autologous whole blood and bone marrow separation.
Cytomedix Receives FDA Approval for Angel PRP SystemWritten by Jaimie Oh | Thursday, 08 November 2012 13:54
Cytomedix has received FDA approval for its Angel concentrated platelet rich plasma system for processing a small sample of blood or a mixture of blood and bone marrow aspirate.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.
New from Becker's Orthopedic & Spine Review